2773-2169

Pharmaceutical Science Advances

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 115 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact115 DOIs
2

Attach ORCID iDs across 30 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact30 DOIs
3

Deposit reference lists for 3 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact3 DOIs

DOIs for this ISSN

Showing the top 5 of 115 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Natural product databases for drug discovery: Features and a… (10.1016/j.pscia.2024.100050)
Abstract ORCID
75.93 32
2 Current status and research progress of oncolytic virus (10.1016/j.pscia.2024.100037)
Abstract ORCID
69.90 24
3 Dual-targeting liposomal delivery of sorafenib and docetaxel… (10.1016/j.pscia.2024.100046)
Abstract ORCID
68.09 22
4 Single-walled carbon nanotubes sensors: Preparation and bio-… (10.1016/j.pscia.2025.100064)
Abstract ORCID
62.76 17
5 Study on the CHJ01 antitumor activity and mechanism via targ… (10.1016/j.pscia.2025.100077)
Abstract ORCID
61.52 16
6 Quercetin inhibits malignant progression of high metastatic… (10.1016/j.pscia.2024.100057)
Abstract ORCID
60.21 15
7 Fuel-propelled nanomotors for acute kidney injury applicatio… (10.1016/j.pscia.2024.100044)
Abstract ORCID
57.31 13
8 Intracellularly driven chemical modifications of antimicrobi… (10.1016/j.pscia.2023.100032)
Abstract ORCID
55.70 12
9 Convergence of computer-aided drug discovery and artificial… (10.1016/j.pscia.2025.100100)
Abstract ORCID
55.70 12
10 The effect of particle size on drug bioavailability in vario… (10.1016/j.pscia.2023.100031)
Abstract
52.34 123
11 Protective effect of lycorine hydrochloride against diabetic… (10.1016/j.pscia.2024.100035)
Abstract ORCID
50.00 9
12 Circular RNA: From non-coding regulators to functional prote… (10.1016/j.pscia.2025.100085)
Abstract ORCID
50.00 9
13 Controlled release of bilayer tablet comprising vitamin B6 r… (10.1016/j.pscia.2023.100008)
Abstract ORCID
47.71 8
14 Nanoplatforms in sepsis storm: Multimodal synergy for precis… (10.1016/j.pscia.2025.100087)
Abstract ORCID
47.71 8
15 Analysis of the underlying mechanism of Ziziphi Spinosae Sem… (10.1016/j.pscia.2023.100019)
Abstract ORCID
42.25 6
16 Homologous tumor cell exosome-based drug delivery system co-… (10.1016/j.pscia.2025.100075)
Abstract ORCID
42.25 6
17 Emerging role of antioxidants in Alzheimer's disease: Insigh… (10.1016/j.pscia.2023.100021)
Abstract
41.33 44
18 Recent progress on formulations of hirudin (10.1016/j.pscia.2025.100078)
Abstract ORCID
38.91 5
19 Targeted drug conjugates in cancer therapy: Challenges and o… (10.1016/j.pscia.2024.100048)
Abstract
38.60 34
20 Covalent coating strategy for enhancing the biocompatibility… (10.1016/j.pscia.2022.100001)
Abstract
36.93 29
21 Design, synthesis, characterization of ferulic acid and p-co… (10.1016/j.pscia.2023.100023)
Abstract
36.18 27
22 Sclareol exerts an anti-inflammatory effect, possibly throug… (10.1016/j.pscia.2023.100029)
Abstract
36.18 27
23 Additive manufacturing in nano drug delivery systems (10.1016/j.pscia.2024.100036)
Abstract
36.18 27
24 Antimicrobial potentials and challenges of paracetamol: A co… (10.1016/j.pscia.2025.100070)
Abstract ORCID
34.95 4
25 Discovery of a long-acting nanocrystal formulation of INND-2… (10.1016/j.pscia.2025.100099)
Abstract ORCID
34.95 4
26 Antimicrobial peptides: A novel and promising arsenal agains… (10.1016/j.pscia.2023.100034)
Abstract
34.04 22
27 Recent progresses in combination cancer therapy using cyanin… (10.1016/j.pscia.2024.100040)
Abstract
34.04 22
28 Rational design of siRNA-based delivery systems for effectiv… (10.1016/j.pscia.2024.100041)
Abstract
33.56 21
29 Structure, functions, and recent advances in the development… (10.1016/j.pscia.2023.100010)
Abstract
33.06 20
30 Potential application of sucrose acetate isobutyrate, and gl… (10.1016/j.pscia.2023.100015)
Abstract
33.06 20
31 Possible hemoglobin enhancing effect of phytol in methotrexa… (10.1016/j.pscia.2024.100043)
Abstract
33.06 20
32 Blockage of HSP90 and IDO1 pathway by α-MSH modified nanoeli… (10.1016/j.pscia.2023.100009)
Abstract ORCID
30.10 3
33 D-pinitol modulates the anti-emetic effects of aprepitant, d… (10.1016/j.pscia.2025.100073)
Abstract ORCID
30.10 3
34 Conquering viral drug resistance: Structural and mechanistic… (10.1016/j.pscia.2025.100094)
Abstract ORCID
30.10 3
35 The most recent advances in liquisolid technology: Perspecti… (10.1016/j.pscia.2024.100038)
Abstract
29.40 14
36 Metal-organic frameworks in pharmaceutical research (10.1016/j.pscia.2025.100096)
Abstract
28.65 13
37 Preparation and characterization of micellar nanoparticles u… (10.1016/j.pscia.2024.100055)
Abstract
27.85 12
38 Investigation of wound healing and anti-inflammatory activit… (10.1016/j.pscia.2023.100016)
Abstract
25.00 9
39 Biowaiver based on biopharmaceutics classification system: C… (10.1016/j.pscia.2023.100020)
Abstract
25.00 9
40 Novel targeted therapies in chronic myeloid leukemia (10.1016/j.pscia.2024.100052)
Abstract
25.00 9
41 Ab initio modeling and ligand docking of quercetin and the M… (10.1016/j.pscia.2023.100011)
Abstract ORCID
23.86 2
42 Immune mechanisms and novel therapies for idiopathic pulmona… (10.1016/j.pscia.2023.100030)
Abstract
23.86 8
43 The crucial role of SPP1 in osteoporosis, osteoarthritis, an… (10.1016/j.pscia.2025.100074)
Abstract
23.86 8
44 Curcumin-loaded gelatin ethosomal gel: A novel approach for… (10.1016/j.pscia.2025.100098)
Abstract ORCID
23.86 2
45 Potential therapeutic effect of Salvia coccinea leaf extract… (10.1016/j.pscia.2023.100017)
Abstract
22.58 7
46 Chemical composition and neuroprotective activity of hemp se… (10.1016/j.pscia.2024.100051)
Abstract
22.58 7
47 Artificial intelligence in human immunodeficiency virus muta… (10.1016/j.pscia.2025.100080)
Abstract
22.58 7
48 Enhancing ferroptosis and inhibiting ABCB1 make the novel al… (10.1016/j.pscia.2025.100088)
Abstract
22.58 7
49 Nanoparticle-enhanced mesalazine therapy for inflammatory bo… (10.1016/j.pscia.2023.100014)
Abstract
21.13 6
50 Flurbiprofen cataplasms: Development and validation of in-vi… (10.1016/j.pscia.2023.100018)
Abstract
21.13 6